[ITCI] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[ITCI] Intra-Cellular Therapies, Inc.
Announcement Date
03-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- 36.27%
YoY- 30.43%
Quarter Report
ITCI's Result
ITCI's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 110,128 94,731 87,433 71,870 55,074 34,755 25,516 165.79%
PBT -42,649 -44,043 -44,026 -53,507 -86,603 -72,114 -85,734 -37.29%
Tax 135 10 -6,772 1 -2,640 5 -541 -
NP -42,784 -44,053 -37,254 -53,508 -83,963 -72,119 -85,734 -37.16%
Tax Rate - - - - - - - -
Total Cost 152,912 138,784 124,687 125,378 139,037 106,874 111,250 23.69%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin -38.85 -46.50 -42.61 -74.45 -152.45 -207.51 -336.00 -76.35%
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -0.45 -0.46 -0.39 -0.57 -0.89 -0.78 -1.05 -43.24%
EPS Diluted -0.45 -0.46 -0.39 -0.57 -0.89 -0.78 -1.05 -43.24%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.